<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>DI243768</GBSeq_locus>
    <GBSeq_length>145</GBSeq_length>
    <GBSeq_strandedness>double</GBSeq_strandedness>
    <GBSeq_moltype>DNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PAT</GBSeq_division>
    <GBSeq_update-date>23-OCT-2013</GBSeq_update-date>
    <GBSeq_create-date>23-OCT-2013</GBSeq_create-date>
    <GBSeq_definition>KR 1020120089743-A/16: NOVEL VIRAL VECTOR CONSTRUCT FOR NEURON SPECIFIC OPTIMIZED CONTINUOUS DOPA SYNTHESIS IN VIVO</GBSeq_definition>
    <GBSeq_primary-accession>DI243768</GBSeq_primary-accession>
    <GBSeq_accession-version>DI243768.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>dbj|DI243768.1|</GBSeqid>
      <GBSeqid>pat|KR|1020120089743|16</GBSeqid>
      <GBSeqid>gi|551462123</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>KR 1020120089743-A/16</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>adeno-associated virus 2</GBSeq_source>
    <GBSeq_organism>adeno-associated virus 2</GBSeq_organism>
    <GBSeq_taxonomy>Viruses; Monodnaviria; Shotokuvirae; Cossaviricota; Quintoviricetes; Piccovirales; Parvoviridae; Parvovirinae; Dependoparvovirus; Dependoparvovirus primate1</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..145</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Bjorklund,T.</GBAuthor>
          <GBAuthor>Bjorklund,A.</GBAuthor>
          <GBAuthor>Kirik,D.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>NOVEL VIRAL VECTOR CONSTRUCT FOR NEURON SPECIFIC OPTIMIZED CONTINUOUS DOPA SYNTHESIS IN VIVO</GBReference_title>
        <GBReference_journal>KR1020120089743-A 16 13-AUG-2012 Genepod Therapeutics AB</GBReference_journal>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>KN KR 1020127014882-A/16~AN KR 1020127014882~AD 2012-06-08~PN KR 1020120089743~PD 2012-08-13~AT NOVEL VIRAL VECTOR CONSTRUCT FOR NEURON SPECIFIC OPTIMIZED AT CONTINUOUS DOPA SYNTHESIS IN VIVO~AI Bjorklund, Tomas|Bjorklund, Anders|Kirik, Deniz AA Genepod Therapeutics AB~PR US 61/259,502=2009-11-09~OS Adeno-associated virus 2~TY DNA.</GBSeq_comment>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..145</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>145</GBInterval_to>
            <GBInterval_accession>DI243768.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>adeno-associated virus 2</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>unassigned DNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:10804</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>aggaacccctagtgatggagttggccactccctctctgcgcgctcgctcgctcactgaggccgcccgggcaaagcccgggcgtcgggcgacctttggtcgcccggcctcagtgagcgagcgagcgcgcagagagggagtggccaa</GBSeq_sequence>
  </GBSeq>
